Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

1.4K
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.4K
The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

4.1K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
4.1K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

4.7K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.7K
Hypertension I: Introduction01:28

Hypertension I: Introduction

1.2K
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
1.2K
Aging01:26

Aging

968
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
968
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

312
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
312

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Case Report: Hyperinflammatory toxicities after Epstein-Barr virus-associated post-transplant lymphoproliferative disorder and hemophagocytic lymphohistiocytosis in a pediatric kidney transplant recipient.

Frontiers in immunology·2026
Same author

Evidence- and Consensus-based European Guideline for Immunosuppressive Therapy After Pediatric Kidney Transplantation.

Transplantation·2026
Same author

Characteristics of children and adolescents with fibromuscular dysplasia: a systematic review and meta-analysis.

Journal of hypertension·2026
Same author

Macroscopic hematuria in children with autosomal dominant polycystic kidney disease - report from four European tertiary centers.

European journal of pediatrics·2026
Same author

Hospital exemption use of virus-specific T-lymphocytes in children: early experience within the Allovista clinical trial framework.

Frontiers in immunology·2026
Same author

Metabolic syndrome and serum uric acid level in children and adolescents with hypertension.

Journal of hypertension·2026

Related Experiment Video

Updated: Mar 23, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.9K

Vascular Aging: Lessons From Pediatric Hypertension.

Mieczyslaw Litwin1, Janusz Feber2, Marcel Ruzicka3

  • 1Department of Nephrology and Hypertension, Children's Memorial Health Institute, Aleja Dzieci Polskich, Warsaw, Poland.

The Canadian Journal of Cardiology
|April 5, 2016
PubMed
Summary

Childhood hypertension (HTN) accelerates vascular aging (EVA), leading to early heart disease. Lifestyle changes and HTN treatment may reverse these vascular changes, improving long-term cardiovascular health.

More Related Videos

Adult Mouse Venous Hypertension Model: Common Carotid Artery to External Jugular Vein Anastomosis.
08:27

Adult Mouse Venous Hypertension Model: Common Carotid Artery to External Jugular Vein Anastomosis.

Published on: January 27, 2015

14.8K
A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats
07:41

A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats

Published on: March 1, 2022

3.5K

Related Experiment Videos

Last Updated: Mar 23, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.9K
Adult Mouse Venous Hypertension Model: Common Carotid Artery to External Jugular Vein Anastomosis.
08:27

Adult Mouse Venous Hypertension Model: Common Carotid Artery to External Jugular Vein Anastomosis.

Published on: January 27, 2015

14.8K
A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats
07:41

A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats

Published on: March 1, 2022

3.5K

Area of Science:

  • Pediatric Cardiology
  • Vascular Biology
  • Public Health

Background:

  • Childhood hypertension (HTN) is linked to early vascular aging (EVA), characterized by accelerated biological maturation and immunologic-metabolic issues.
  • Vascular changes in pediatric HTN, such as increased intima-media thickness (IMT) and arterial stiffness, mirror those seen in elderly individuals.
  • While rare progeria causes EVA and early cardiovascular disease, primary HTN associated with EVA is more prevalent in adolescents (up to 10%).

Purpose of the Study:

  • To investigate the association between hypertension and early vascular aging in children.
  • To explore the potential for reversing EVA-related vascular changes through interventions.
  • To highlight the long-term cardiovascular implications of pediatric HTN and EVA.

Main Methods:

  • Review of prospective observational studies in children and adolescents.
  • Analysis of morphologic and functional vascular changes (e.g., carotid IMT, pulse wave velocity, flow-mediated dilation).
  • Assessment of biomarkers including oxidative stress and visceral fat.

Main Results:

  • Pediatric HTN is associated with EVA, leading to premature target organ injury and increased risk of cardiovascular events in early adulthood.
  • Early lifestyle interventions (diet, exercise) and/or pharmacologic HTN treatment show potential to partially reverse vascular changes.
  • Observed reversals include decreased carotid IMT, improved pulse wave velocity, enhanced flow-mediated dilation, reduced oxidative stress, and decreased visceral fat.

Conclusions:

  • Hypertension in children significantly contributes to early vascular aging and future cardiovascular risks.
  • Interventions targeting HTN and lifestyle factors in childhood may mitigate or reverse vascular aging processes.
  • Further clinical trials are needed to elucidate mechanisms and optimize treatment strategies for EVA in pediatric HTN.